Report banner
Home
Industries
Healthcare
Autoimmune Disease Diagnostics Market
Updated On

Jan 31 2025

Total Pages

190

Market
Insights

7,500+

Reports delivered globally, covering a wide range of industries and sectors.

2,350+

Clients who trust our expertise and rely on our insights for business decisions.

1,050+

Managed Reports, ensuring seamless updates and premium service.

100%

Satisfied Customers, committed to delivering exceptional value and quality.

Autoimmune Disease Diagnostics Market 2025 to Grow at 5.9 CAGR with 5.3 Billion Market Size: Analysis and Forecasts 2033

Autoimmune Disease Diagnostics Market by Product (Reagents and consumables, Instruments), by Disease Type (Systemic autoimmune disease, Localized autoimmune disease), by Test Type (Antinuclear antibody tests, Autoantibody tests, C-reactive protein (CRP), Complete blood count (CBC), Urinalysis, Other tests), by End-use (Hospitals, Diagnostics centers, Other end-users), by North America (U.S., Canada), by Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), by Asia Pacific (China, Japan, India, Australia, South Korea, Rest of Asia Pacific), by Latin America (Brazil, Mexico, Argentina, Rest of Latin America), by Middle East and Africa (South Africa, Saudi Arabia, UAE, Rest of Middle East and Africa) Forecast 2025-2033

Main Logo

Autoimmune Disease Diagnostics Market 2025 to Grow at 5.9 CAGR with 5.3 Billion Market Size: Analysis and Forecasts 2033

Key Insights

The size of the Autoimmune Disease Diagnostics Market market was valued at USD 5.3 Billion in 2024 and is projected to reach USD 7.92 Billion by 2033, with an expected CAGR of 5.9% during the forecast period. Due to the increased number of cases such as rheumatoid arthritis, lupus, type 1 diabetes, multiple sclerosis, and celiac diseases, the growth in the autoimmunity disorder diagnostics market has been considerable in recent years. Increased awareness along with advances in diagnostic technologies along with an emerging trend towards more personalized medicine fuels the expansion in the market. Early diagnosis significantly determines the approach towards effective control of autoimmune disease, hence advanced diagnostic solutions require investment by providers. Lots of technologies include ELISA, immunofluorescence assays, molecular diagnostics for detecting autoimmunity disorders, and a lot of innovations are made due to the growing demand for diagnostic techniques non-invasive and rapid. Genetic predisposition and other environmental and lifestyle changes seem to have set behind the growth of autoimmune diseases. Favorable government initiatives, research funding, and close collaborations between diagnostic companies and healthcare institutions support market growth. North America leads the way because of high health care expenditure, a developed infrastructure, and presence of major industry players. However, the Asia-Pacific region is expected to grow at the fastest rate due to rising healthcare awareness and improved access to diagnostic facilities.

Autoimmune Disease Diagnostics Market Research Report - Market Size, Growth & Forecast

Autoimmune Disease Diagnostics Market Concentration & Characteristics

  • Concentration Areas The autoimmune disease diagnostics market is moderately concentrated, with leading players holding significant market share.
  • Characteristics Innovation: Continuous advancements in diagnostic technologies, such as AI-powered algorithms and multiplex assays, are shaping the market. 
  • Regulations: Stringent regulations governing diagnostic tests ensure accuracy and reliability. 
  • Product Substitutes: Limited availability of substitutes for established diagnostic tests. 
  • End-User Concentration: Hospitals and diagnostic centers are the primary end-users of autoimmune disease diagnostics. 
  • M&A Activity: Strategic acquisitions and collaborations among industry players strengthen market positions.

Autoimmune Disease Diagnostics Market Trends

Personalized Medicine: Precision diagnostics using genetic and molecular profiling aids in tailored treatment plans. Early Disease Detection: Novel technologies allow for early detection of autoimmune diseases, improving patient outcomes. Remote Patient Monitoring: Technological advancements facilitate remote monitoring of disease activity and treatment response. Focus on Point-of-Care Testing: Compact and portable diagnostic devices enable point-of-care testing, increasing accessibility.

Autoimmune Disease Diagnostics Market Growth

Key Region or Country to Dominate the Market

  • Region: North America dominates the market due to a high prevalence of autoimmune diseases, advanced healthcare infrastructure, and extensive investment in research and development. 
  • Country: The United States is the largest market in North America, accounting for a significant share of revenue.

Autoimmune Disease Diagnostics Market Segmentation

Product:

  • Reagents and consumables
  • Instruments

Disease Type:

  • Systemic autoimmune disease
  • Localized autoimmune disease

Test Type:

  • Antinuclear antibody tests
  • Autoantibody tests
  • C-reactive protein (CRP)

End-Use:

  • Hospitals
  • Diagnostics centers

Autoimmune Disease Diagnostics Market Product Insights

Reagents and consumables contribute the largest revenue share due to their extensive use in various diagnostic tests.

Autoimmune Disease Diagnostics Market Analysis

The market has experienced steady growth, attributed to the increasing incidence of autoimmune diseases. Key players are investing in R&D to develop innovative diagnostic solutions.

Autoimmune Disease Diagnostics Market Regional Insights

  • North America: Dominates the market with significant revenue contribution. 
  • Europe: Ranks second, driven by advanced healthcare infrastructure and high healthcare spending. 
  • Asia-Pacific: Exhibits strong growth potential due to a large and growing population with increasing awareness of autoimmune diseases.

Driving Forces: What's Propelling the Autoimmune Disease Diagnostics Market

  • Rising prevalence of autoimmune diseases
  • Technological advancements
  • Growing awareness about autoimmune conditions

Challenges and Restraints in the Autoimmune Disease Diagnostics Market

  • Limited sensitivity and specificity of certain diagnostic tests
  • High cost of advanced diagnostic technologies

Emerging Trends in Autoimmune Disease Diagnostics Market

  • Integration of AI and machine learning algorithms
  • Non-invasive diagnostic methods
  • Personalized and precision diagnostics

Autoimmune Disease Diagnostics Industry News

May 2022: Thermo Fisher Scientific launched the Phadia 2500+ Instrument, a device aiding in the diagnosis of various autoimmune diseases.

Leading Players in the Autoimmune Disease Diagnostics Market

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • DIAsource ImmunoAssays SA
  • Euroimmun AG (Perkin Elmer)
  • F. Hoffmann-la Roche Ltd.
  • Hemagen Diagnostics
  • Myriad Genetics
  • Quest Diagnostics
  • Siemens Healthineers Inc
  • SQI Diagnostics Inc.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc

Autoimmune Disease Diagnostics Market Segmentation

  • 1. Product
    • 1.1. Reagents and consumables
    • 1.2. Instruments
  • 2. Disease Type
    • 2.1. Systemic autoimmune disease
    • 2.2. Localized autoimmune disease
  • 3. Test Type
    • 3.1. Antinuclear antibody tests
    • 3.2. Autoantibody tests
    • 3.3. C-reactive protein (CRP)
    • 3.4. Complete blood count (CBC)
    • 3.5. Urinalysis
    • 3.6. Other tests
  • 4. End-use
    • 4.1. Hospitals
    • 4.2. Diagnostics centers
    • 4.3. Other end-users

Autoimmune Disease Diagnostics Market Segmentation By Geography

  • 1. North America
    • 1.1. U.S.
    • 1.2. Canada
  • 2. Europe
    • 2.1. Germany
    • 2.2. U.K.
    • 2.3. France
    • 2.4. Spain
    • 2.5. Italy
    • 2.6. Rest of Europe
  • 3. Asia Pacific
    • 3.1. China
    • 3.2. Japan
    • 3.3. India
    • 3.4. Australia
    • 3.5. South Korea
    • 3.6. Rest of Asia Pacific
  • 4. Latin America
    • 4.1. Brazil
    • 4.2. Mexico
    • 4.3. Argentina
    • 4.4. Rest of Latin America
  • 5. Middle East and Africa
    • 5.1. South Africa
    • 5.2. Saudi Arabia
    • 5.3. UAE
    • 5.4. Rest of Middle East and Africa

Autoimmune Disease Diagnostics Market Regional Share

Autoimmune Disease Diagnostics Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2019-2033
Base Year 2024
Estimated Year 2025
Forecast Period2025-2033
Historical Period2019-2024
Growth RateCAGR of 5.9% from 2019-2033
Segmentation
    • By Product
      • Reagents and consumables
      • Instruments
    • By Disease Type
      • Systemic autoimmune disease
        • Rheumatoid arthritis
        • Systemic lupus erythematosus (SLE)
        • Psoriasis
        • Multiple sclerosis
        • Other systemic autoimmune diseases
      • Localized autoimmune disease
        • Inflammatory bowel disease
        • Type 1 diabetes
        • Thyroid
        • Other localized autoimmune diseases
    • By Test Type
      • Antinuclear antibody tests
      • Autoantibody tests
      • C-reactive protein (CRP)
      • Complete blood count (CBC)
      • Urinalysis
      • Other tests
    • By End-use
      • Hospitals
      • Diagnostics centers
      • Other end-users
  • By Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Middle East and Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of Middle East and Africa
Table Of Content
  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1 High incidence and prevalence of autoimmune diseases
        • 3.2.2 Growing awareness about autoimmune diseases
        • 3.2.3 Supportive government policies for research activities on autoimmune diseases
        • 3.2.4 Technological advancements and increasing adoption of lab automation technologies
      • 3.3. Market Restrains
        • 3.3.1 Need for high capital investment in setting-up diagnosis centers
        • 3.3.2 Slow turnaround time for test results and need for multiple diagnostic tests
      • 3.4. Market Trends
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global Autoimmune Disease Diagnostics Market Analysis, Insights and Forecast, 2019-2031
    • 5.1. Market Analysis, Insights and Forecast - by Product
      • 5.1.1. Reagents and consumables
      • 5.1.2. Instruments
    • 5.2. Market Analysis, Insights and Forecast - by Disease Type
      • 5.2.1. Systemic autoimmune disease
        • 5.2.1.1. Rheumatoid arthritis
        • 5.2.1.2. Systemic lupus erythematosus (SLE)
        • 5.2.1.3. Psoriasis
        • 5.2.1.4. Multiple sclerosis
        • 5.2.1.5. Other systemic autoimmune diseases
      • 5.2.2. Localized autoimmune disease
        • 5.2.2.1. Inflammatory bowel disease
        • 5.2.2.2. Type 1 diabetes
        • 5.2.2.3. Thyroid
        • 5.2.2.4. Other localized autoimmune diseases
    • 5.3. Market Analysis, Insights and Forecast - by Test Type
      • 5.3.1. Antinuclear antibody tests
      • 5.3.2. Autoantibody tests
      • 5.3.3. C-reactive protein (CRP)
      • 5.3.4. Complete blood count (CBC)
      • 5.3.5. Urinalysis
      • 5.3.6. Other tests
    • 5.4. Market Analysis, Insights and Forecast - by End-use
      • 5.4.1. Hospitals
      • 5.4.2. Diagnostics centers
      • 5.4.3. Other end-users
    • 5.5. Market Analysis, Insights and Forecast - by Region
      • 5.5.1. North America
      • 5.5.2. Europe
      • 5.5.3. Asia Pacific
      • 5.5.4. Latin America
      • 5.5.5. Middle East and Africa
  6. 6. North America Autoimmune Disease Diagnostics Market Analysis, Insights and Forecast, 2019-2031
    • 6.1. Market Analysis, Insights and Forecast - by Product
      • 6.1.1. Reagents and consumables
      • 6.1.2. Instruments
    • 6.2. Market Analysis, Insights and Forecast - by Disease Type
      • 6.2.1. Systemic autoimmune disease
        • 6.2.1.1. Rheumatoid arthritis
        • 6.2.1.2. Systemic lupus erythematosus (SLE)
        • 6.2.1.3. Psoriasis
        • 6.2.1.4. Multiple sclerosis
        • 6.2.1.5. Other systemic autoimmune diseases
      • 6.2.2. Localized autoimmune disease
        • 6.2.2.1. Inflammatory bowel disease
        • 6.2.2.2. Type 1 diabetes
        • 6.2.2.3. Thyroid
        • 6.2.2.4. Other localized autoimmune diseases
    • 6.3. Market Analysis, Insights and Forecast - by Test Type
      • 6.3.1. Antinuclear antibody tests
      • 6.3.2. Autoantibody tests
      • 6.3.3. C-reactive protein (CRP)
      • 6.3.4. Complete blood count (CBC)
      • 6.3.5. Urinalysis
      • 6.3.6. Other tests
    • 6.4. Market Analysis, Insights and Forecast - by End-use
      • 6.4.1. Hospitals
      • 6.4.2. Diagnostics centers
      • 6.4.3. Other end-users
  7. 7. Europe Autoimmune Disease Diagnostics Market Analysis, Insights and Forecast, 2019-2031
    • 7.1. Market Analysis, Insights and Forecast - by Product
      • 7.1.1. Reagents and consumables
      • 7.1.2. Instruments
    • 7.2. Market Analysis, Insights and Forecast - by Disease Type
      • 7.2.1. Systemic autoimmune disease
        • 7.2.1.1. Rheumatoid arthritis
        • 7.2.1.2. Systemic lupus erythematosus (SLE)
        • 7.2.1.3. Psoriasis
        • 7.2.1.4. Multiple sclerosis
        • 7.2.1.5. Other systemic autoimmune diseases
      • 7.2.2. Localized autoimmune disease
        • 7.2.2.1. Inflammatory bowel disease
        • 7.2.2.2. Type 1 diabetes
        • 7.2.2.3. Thyroid
        • 7.2.2.4. Other localized autoimmune diseases
    • 7.3. Market Analysis, Insights and Forecast - by Test Type
      • 7.3.1. Antinuclear antibody tests
      • 7.3.2. Autoantibody tests
      • 7.3.3. C-reactive protein (CRP)
      • 7.3.4. Complete blood count (CBC)
      • 7.3.5. Urinalysis
      • 7.3.6. Other tests
    • 7.4. Market Analysis, Insights and Forecast - by End-use
      • 7.4.1. Hospitals
      • 7.4.2. Diagnostics centers
      • 7.4.3. Other end-users
  8. 8. Asia Pacific Autoimmune Disease Diagnostics Market Analysis, Insights and Forecast, 2019-2031
    • 8.1. Market Analysis, Insights and Forecast - by Product
      • 8.1.1. Reagents and consumables
      • 8.1.2. Instruments
    • 8.2. Market Analysis, Insights and Forecast - by Disease Type
      • 8.2.1. Systemic autoimmune disease
        • 8.2.1.1. Rheumatoid arthritis
        • 8.2.1.2. Systemic lupus erythematosus (SLE)
        • 8.2.1.3. Psoriasis
        • 8.2.1.4. Multiple sclerosis
        • 8.2.1.5. Other systemic autoimmune diseases
      • 8.2.2. Localized autoimmune disease
        • 8.2.2.1. Inflammatory bowel disease
        • 8.2.2.2. Type 1 diabetes
        • 8.2.2.3. Thyroid
        • 8.2.2.4. Other localized autoimmune diseases
    • 8.3. Market Analysis, Insights and Forecast - by Test Type
      • 8.3.1. Antinuclear antibody tests
      • 8.3.2. Autoantibody tests
      • 8.3.3. C-reactive protein (CRP)
      • 8.3.4. Complete blood count (CBC)
      • 8.3.5. Urinalysis
      • 8.3.6. Other tests
    • 8.4. Market Analysis, Insights and Forecast - by End-use
      • 8.4.1. Hospitals
      • 8.4.2. Diagnostics centers
      • 8.4.3. Other end-users
  9. 9. Latin America Autoimmune Disease Diagnostics Market Analysis, Insights and Forecast, 2019-2031
    • 9.1. Market Analysis, Insights and Forecast - by Product
      • 9.1.1. Reagents and consumables
      • 9.1.2. Instruments
    • 9.2. Market Analysis, Insights and Forecast - by Disease Type
      • 9.2.1. Systemic autoimmune disease
        • 9.2.1.1. Rheumatoid arthritis
        • 9.2.1.2. Systemic lupus erythematosus (SLE)
        • 9.2.1.3. Psoriasis
        • 9.2.1.4. Multiple sclerosis
        • 9.2.1.5. Other systemic autoimmune diseases
      • 9.2.2. Localized autoimmune disease
        • 9.2.2.1. Inflammatory bowel disease
        • 9.2.2.2. Type 1 diabetes
        • 9.2.2.3. Thyroid
        • 9.2.2.4. Other localized autoimmune diseases
    • 9.3. Market Analysis, Insights and Forecast - by Test Type
      • 9.3.1. Antinuclear antibody tests
      • 9.3.2. Autoantibody tests
      • 9.3.3. C-reactive protein (CRP)
      • 9.3.4. Complete blood count (CBC)
      • 9.3.5. Urinalysis
      • 9.3.6. Other tests
    • 9.4. Market Analysis, Insights and Forecast - by End-use
      • 9.4.1. Hospitals
      • 9.4.2. Diagnostics centers
      • 9.4.3. Other end-users
  10. 10. Middle East and Africa Autoimmune Disease Diagnostics Market Analysis, Insights and Forecast, 2019-2031
    • 10.1. Market Analysis, Insights and Forecast - by Product
      • 10.1.1. Reagents and consumables
      • 10.1.2. Instruments
    • 10.2. Market Analysis, Insights and Forecast - by Disease Type
      • 10.2.1. Systemic autoimmune disease
        • 10.2.1.1. Rheumatoid arthritis
        • 10.2.1.2. Systemic lupus erythematosus (SLE)
        • 10.2.1.3. Psoriasis
        • 10.2.1.4. Multiple sclerosis
        • 10.2.1.5. Other systemic autoimmune diseases
      • 10.2.2. Localized autoimmune disease
        • 10.2.2.1. Inflammatory bowel disease
        • 10.2.2.2. Type 1 diabetes
        • 10.2.2.3. Thyroid
        • 10.2.2.4. Other localized autoimmune diseases
    • 10.3. Market Analysis, Insights and Forecast - by Test Type
      • 10.3.1. Antinuclear antibody tests
      • 10.3.2. Autoantibody tests
      • 10.3.3. C-reactive protein (CRP)
      • 10.3.4. Complete blood count (CBC)
      • 10.3.5. Urinalysis
      • 10.3.6. Other tests
    • 10.4. Market Analysis, Insights and Forecast - by End-use
      • 10.4.1. Hospitals
      • 10.4.2. Diagnostics centers
      • 10.4.3. Other end-users
  11. 11. Competitive Analysis
    • 11.1. Global Market Share Analysis 2024
      • 11.2. Company Profiles
        • 11.2.1 Abbott Laboratories
          • 11.2.1.1. Overview
          • 11.2.1.2. Products
          • 11.2.1.3. SWOT Analysis
          • 11.2.1.4. Recent Developments
          • 11.2.1.5. Financials (Based on Availability)
        • 11.2.2 Bio-Rad Laboratories Inc.
          • 11.2.2.1. Overview
          • 11.2.2.2. Products
          • 11.2.2.3. SWOT Analysis
          • 11.2.2.4. Recent Developments
          • 11.2.2.5. Financials (Based on Availability)
        • 11.2.3 DIAsource ImmunoAssays SA
          • 11.2.3.1. Overview
          • 11.2.3.2. Products
          • 11.2.3.3. SWOT Analysis
          • 11.2.3.4. Recent Developments
          • 11.2.3.5. Financials (Based on Availability)
        • 11.2.4 Euroimmun AG (Perkin Elmer)
          • 11.2.4.1. Overview
          • 11.2.4.2. Products
          • 11.2.4.3. SWOT Analysis
          • 11.2.4.4. Recent Developments
          • 11.2.4.5. Financials (Based on Availability)
        • 11.2.5 F. Hoffmann-la Roche Ltd.
          • 11.2.5.1. Overview
          • 11.2.5.2. Products
          • 11.2.5.3. SWOT Analysis
          • 11.2.5.4. Recent Developments
          • 11.2.5.5. Financials (Based on Availability)
        • 11.2.6 Hemagen Diagnostics
          • 11.2.6.1. Overview
          • 11.2.6.2. Products
          • 11.2.6.3. SWOT Analysis
          • 11.2.6.4. Recent Developments
          • 11.2.6.5. Financials (Based on Availability)
        • 11.2.7 Myriad Genetics
          • 11.2.7.1. Overview
          • 11.2.7.2. Products
          • 11.2.7.3. SWOT Analysis
          • 11.2.7.4. Recent Developments
          • 11.2.7.5. Financials (Based on Availability)
        • 11.2.8 Quest Diagnostics
          • 11.2.8.1. Overview
          • 11.2.8.2. Products
          • 11.2.8.3. SWOT Analysis
          • 11.2.8.4. Recent Developments
          • 11.2.8.5. Financials (Based on Availability)
        • 11.2.9 Siemens Healthineers Inc
          • 11.2.9.1. Overview
          • 11.2.9.2. Products
          • 11.2.9.3. SWOT Analysis
          • 11.2.9.4. Recent Developments
          • 11.2.9.5. Financials (Based on Availability)
        • 11.2.10 SQI Diagnostics Inc.
          • 11.2.10.1. Overview
          • 11.2.10.2. Products
          • 11.2.10.3. SWOT Analysis
          • 11.2.10.4. Recent Developments
          • 11.2.10.5. Financials (Based on Availability)
        • 11.2.11 Thermo Fisher Scientific Inc.
          • 11.2.11.1. Overview
          • 11.2.11.2. Products
          • 11.2.11.3. SWOT Analysis
          • 11.2.11.4. Recent Developments
          • 11.2.11.5. Financials (Based on Availability)
        • 11.2.12 Trinity Biotech Plc.
          • 11.2.12.1. Overview
          • 11.2.12.2. Products
          • 11.2.12.3. SWOT Analysis
          • 11.2.12.4. Recent Developments
          • 11.2.12.5. Financials (Based on Availability)
List of Figures
  1. Figure 1: Global Autoimmune Disease Diagnostics Market Revenue Breakdown (Billion, %) by Region 2024 & 2032
  2. Figure 2: North America Autoimmune Disease Diagnostics Market Revenue (Billion), by Product 2024 & 2032
  3. Figure 3: North America Autoimmune Disease Diagnostics Market Revenue Share (%), by Product 2024 & 2032
  4. Figure 4: North America Autoimmune Disease Diagnostics Market Revenue (Billion), by Disease Type 2024 & 2032
  5. Figure 5: North America Autoimmune Disease Diagnostics Market Revenue Share (%), by Disease Type 2024 & 2032
  6. Figure 6: North America Autoimmune Disease Diagnostics Market Revenue (Billion), by Test Type 2024 & 2032
  7. Figure 7: North America Autoimmune Disease Diagnostics Market Revenue Share (%), by Test Type 2024 & 2032
  8. Figure 8: North America Autoimmune Disease Diagnostics Market Revenue (Billion), by End-use 2024 & 2032
  9. Figure 9: North America Autoimmune Disease Diagnostics Market Revenue Share (%), by End-use 2024 & 2032
  10. Figure 10: North America Autoimmune Disease Diagnostics Market Revenue (Billion), by Country 2024 & 2032
  11. Figure 11: North America Autoimmune Disease Diagnostics Market Revenue Share (%), by Country 2024 & 2032
  12. Figure 12: Europe Autoimmune Disease Diagnostics Market Revenue (Billion), by Product 2024 & 2032
  13. Figure 13: Europe Autoimmune Disease Diagnostics Market Revenue Share (%), by Product 2024 & 2032
  14. Figure 14: Europe Autoimmune Disease Diagnostics Market Revenue (Billion), by Disease Type 2024 & 2032
  15. Figure 15: Europe Autoimmune Disease Diagnostics Market Revenue Share (%), by Disease Type 2024 & 2032
  16. Figure 16: Europe Autoimmune Disease Diagnostics Market Revenue (Billion), by Test Type 2024 & 2032
  17. Figure 17: Europe Autoimmune Disease Diagnostics Market Revenue Share (%), by Test Type 2024 & 2032
  18. Figure 18: Europe Autoimmune Disease Diagnostics Market Revenue (Billion), by End-use 2024 & 2032
  19. Figure 19: Europe Autoimmune Disease Diagnostics Market Revenue Share (%), by End-use 2024 & 2032
  20. Figure 20: Europe Autoimmune Disease Diagnostics Market Revenue (Billion), by Country 2024 & 2032
  21. Figure 21: Europe Autoimmune Disease Diagnostics Market Revenue Share (%), by Country 2024 & 2032
  22. Figure 22: Asia Pacific Autoimmune Disease Diagnostics Market Revenue (Billion), by Product 2024 & 2032
  23. Figure 23: Asia Pacific Autoimmune Disease Diagnostics Market Revenue Share (%), by Product 2024 & 2032
  24. Figure 24: Asia Pacific Autoimmune Disease Diagnostics Market Revenue (Billion), by Disease Type 2024 & 2032
  25. Figure 25: Asia Pacific Autoimmune Disease Diagnostics Market Revenue Share (%), by Disease Type 2024 & 2032
  26. Figure 26: Asia Pacific Autoimmune Disease Diagnostics Market Revenue (Billion), by Test Type 2024 & 2032
  27. Figure 27: Asia Pacific Autoimmune Disease Diagnostics Market Revenue Share (%), by Test Type 2024 & 2032
  28. Figure 28: Asia Pacific Autoimmune Disease Diagnostics Market Revenue (Billion), by End-use 2024 & 2032
  29. Figure 29: Asia Pacific Autoimmune Disease Diagnostics Market Revenue Share (%), by End-use 2024 & 2032
  30. Figure 30: Asia Pacific Autoimmune Disease Diagnostics Market Revenue (Billion), by Country 2024 & 2032
  31. Figure 31: Asia Pacific Autoimmune Disease Diagnostics Market Revenue Share (%), by Country 2024 & 2032
  32. Figure 32: Latin America Autoimmune Disease Diagnostics Market Revenue (Billion), by Product 2024 & 2032
  33. Figure 33: Latin America Autoimmune Disease Diagnostics Market Revenue Share (%), by Product 2024 & 2032
  34. Figure 34: Latin America Autoimmune Disease Diagnostics Market Revenue (Billion), by Disease Type 2024 & 2032
  35. Figure 35: Latin America Autoimmune Disease Diagnostics Market Revenue Share (%), by Disease Type 2024 & 2032
  36. Figure 36: Latin America Autoimmune Disease Diagnostics Market Revenue (Billion), by Test Type 2024 & 2032
  37. Figure 37: Latin America Autoimmune Disease Diagnostics Market Revenue Share (%), by Test Type 2024 & 2032
  38. Figure 38: Latin America Autoimmune Disease Diagnostics Market Revenue (Billion), by End-use 2024 & 2032
  39. Figure 39: Latin America Autoimmune Disease Diagnostics Market Revenue Share (%), by End-use 2024 & 2032
  40. Figure 40: Latin America Autoimmune Disease Diagnostics Market Revenue (Billion), by Country 2024 & 2032
  41. Figure 41: Latin America Autoimmune Disease Diagnostics Market Revenue Share (%), by Country 2024 & 2032
  42. Figure 42: Middle East and Africa Autoimmune Disease Diagnostics Market Revenue (Billion), by Product 2024 & 2032
  43. Figure 43: Middle East and Africa Autoimmune Disease Diagnostics Market Revenue Share (%), by Product 2024 & 2032
  44. Figure 44: Middle East and Africa Autoimmune Disease Diagnostics Market Revenue (Billion), by Disease Type 2024 & 2032
  45. Figure 45: Middle East and Africa Autoimmune Disease Diagnostics Market Revenue Share (%), by Disease Type 2024 & 2032
  46. Figure 46: Middle East and Africa Autoimmune Disease Diagnostics Market Revenue (Billion), by Test Type 2024 & 2032
  47. Figure 47: Middle East and Africa Autoimmune Disease Diagnostics Market Revenue Share (%), by Test Type 2024 & 2032
  48. Figure 48: Middle East and Africa Autoimmune Disease Diagnostics Market Revenue (Billion), by End-use 2024 & 2032
  49. Figure 49: Middle East and Africa Autoimmune Disease Diagnostics Market Revenue Share (%), by End-use 2024 & 2032
  50. Figure 50: Middle East and Africa Autoimmune Disease Diagnostics Market Revenue (Billion), by Country 2024 & 2032
  51. Figure 51: Middle East and Africa Autoimmune Disease Diagnostics Market Revenue Share (%), by Country 2024 & 2032
List of Tables
  1. Table 1: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Region 2019 & 2032
  2. Table 2: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Product 2019 & 2032
  3. Table 3: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Disease Type 2019 & 2032
  4. Table 4: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Test Type 2019 & 2032
  5. Table 5: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by End-use 2019 & 2032
  6. Table 6: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Region 2019 & 2032
  7. Table 7: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Product 2019 & 2032
  8. Table 8: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Disease Type 2019 & 2032
  9. Table 9: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Test Type 2019 & 2032
  10. Table 10: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by End-use 2019 & 2032
  11. Table 11: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Country 2019 & 2032
  12. Table 12: U.S. Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  13. Table 13: Canada Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  14. Table 14: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Product 2019 & 2032
  15. Table 15: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Disease Type 2019 & 2032
  16. Table 16: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Test Type 2019 & 2032
  17. Table 17: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by End-use 2019 & 2032
  18. Table 18: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Country 2019 & 2032
  19. Table 19: Germany Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  20. Table 20: U.K. Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  21. Table 21: France Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  22. Table 22: Spain Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  23. Table 23: Italy Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  24. Table 24: Rest of Europe Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  25. Table 25: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Product 2019 & 2032
  26. Table 26: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Disease Type 2019 & 2032
  27. Table 27: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Test Type 2019 & 2032
  28. Table 28: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by End-use 2019 & 2032
  29. Table 29: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Country 2019 & 2032
  30. Table 30: China Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  31. Table 31: Japan Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  32. Table 32: India Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  33. Table 33: Australia Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  34. Table 34: South Korea Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  35. Table 35: Rest of Asia Pacific Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  36. Table 36: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Product 2019 & 2032
  37. Table 37: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Disease Type 2019 & 2032
  38. Table 38: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Test Type 2019 & 2032
  39. Table 39: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by End-use 2019 & 2032
  40. Table 40: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Country 2019 & 2032
  41. Table 41: Brazil Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  42. Table 42: Mexico Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  43. Table 43: Argentina Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  44. Table 44: Rest of Latin America Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  45. Table 45: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Product 2019 & 2032
  46. Table 46: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Disease Type 2019 & 2032
  47. Table 47: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Test Type 2019 & 2032
  48. Table 48: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by End-use 2019 & 2032
  49. Table 49: Global Autoimmune Disease Diagnostics Market Revenue Billion Forecast, by Country 2019 & 2032
  50. Table 50: South Africa Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  51. Table 51: Saudi Arabia Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  52. Table 52: UAE Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032
  53. Table 53: Rest of Middle East and Africa Autoimmune Disease Diagnostics Market Revenue (Billion) Forecast, by Application 2019 & 2032

STEP 1 - Identification of Relevant Samples Size from Population Database

Step Chart
bar chart
method chart

STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

approach chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.

Note* : In applicable scenarios

STEP 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
approach chart

STEP 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.

Frequently Asked Questions

Get a Free Sample

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

Pricing

$4,850
Single User License:
  • Only one user can access this report at a time
  • Users are not allowed to take a print out of the report PDF
$5,350
Multi User License:
  • The report will be emailed to you in PDF format.
  • Allows 1-10 employees within your organisation to access the report.
$8,350
Corporate License:
  • Sharable and Printable among all employees of your organization
  • Excel Raw data with access to full quantitative & financial market insights
  • Customization at no additional cost within the scope of the report
  • Graphs and Charts can be used during presentation

Looking for a Custom Report?

We offer personalized report customization at no extra cost, including the option to purchase individual sections or country-specific reports. Plus, we provide special discounts for startups and universities. Get in touch with us today!

sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
avatar

Director of Business Development

Sarah L

The insights provided in this report were spot-on and exactly what we needed to guide our strategic planning. The level of detail on industry trends and forecasts is unmatched. It saved us countless hours and gave us a significant advantage!"

Discover the Latest Market Insight Reports

Access in-depth insights on industries, companies, trends, and global markets. Our expertly curated reports provide the most relevant data and analysis in a condensed, easy-to-read format.

shop image 1

About Market Insights Report

Market Insights Reports offers comprehensive market research reports and analysis, giving businesses important information about their clients, rivals, and sector to help them make well-informed decisions on operations, marketing, and business strategy. We offer a variety of services in addition to market research, data analysis, and strategy planning. In order to find opportunities and learn more about our competitors and the industry at large, we employ competitive analysis. To identify areas for development, we also evaluate our performance against that of our rivals. We can determine the places at which we can offer our clients the most value by performing value chain analysis.

Additionally, clients receive a thorough overview of their industry business environment. We can find trends that help us forecast future possibilities and threats by examining global macroeconomic dynamics and consumer behavior patterns. By analyzing their features and advantages, contrasting them with comparable items on the market, and evaluating both their quantitative and qualitative performance, we comprehensively evaluate our clients' products. This allows us to assist customers in determining how their goods compare to those of their rivals and in creating successful marketing plans. Our group has been successful in gaining a thorough grasp of our clients' requirements and offering them creative solutions. We currently provide services to more than 50 nations in Europe, the Middle East, Africa, Latin America, Asia Pacific, and North America. Because of our global reach, we have been able to establish trusting bonds with our partners and clients in various nations, improving customer service and forging a more cohesive worldwide presence.

+1 2315155523

sales@marketinsights.report

  • Home
  • About Us
  • Industries
    • Aerospace & Defense
    • Automotive
    • Semiconductors & Electronics
    • Agriculture
    • Chemicals & Materials
    • Construction
    • Consumer Goods and Services
    • Energy & Power
    • Food & Beverage
    • Healthcare
    • Media & Technology
    • Industrial Machinery
    • Packaging
    • Professional Services
    • Animal Health & Nutrition
  • Services
  • Contact
Main Logo
  • Home
  • About Us
  • Industries
    • Aerospace & Defense
    • Automotive
    • Semiconductors & Electronics
    • Agriculture
    • Chemicals & Materials
    • Construction
    • Consumer Goods and Services
    • Energy & Power
    • Food & Beverage
    • Healthcare
    • Media & Technology
    • Industrial Machinery
    • Packaging
    • Professional Services
    • Animal Health & Nutrition
  • Services
  • Contact
sales@marketinsights.report

Business Address

Head Office

Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014

Contact Information

Craig Francis

Business Development Head

+1 2315155523

sales@marketinsights.report

Extra Links

AboutContactsTestimonials
ServicesCareer

Subscribe

Get the latest updates and offers.

PackagingAutomotiveHealthcareAgricultureConstructionEnergy & PowerFood & BeverageMedia & TechnologyAerospace & DefenseIndustrial MachineryChemicals & MaterialsProfessional ServicesAnimal Health & NutritionConsumer Goods and ServicesSemiconductors & Electronics

© 2025 AMA Research. All rights reserved

Testimonials
Privacy Policy
Terms and Conditions
FAQ

Related Reports

See the similar reports

report thumbnailAutoimmune Disease Diagnostics Market

Autoimmune Disease Diagnostics Market 2025 to Grow at 5.9 CAGR with 5.3 Billion Market Size: Analysis and Forecasts 2033

report thumbnailReal-time Location Systems (RTLS) for Hospital Beds Market

Real-time Location Systems (RTLS) for Hospital Beds Market 19 CAGR Growth Outlook 2025-2033

report thumbnailSleep Tech Devices Market

Sleep Tech Devices Market 2025 to Grow at 18.3 CAGR with 21.1 Billion Market Size: Analysis and Forecasts 2033

report thumbnailDipeptidyl Peptidase 4 Inhibitors Market

Dipeptidyl Peptidase 4 Inhibitors Market Strategic Insights for 2025 and Forecasts to 2033: Market Trends

report thumbnailHealthcare Wearable Robots Market

Healthcare Wearable Robots Market 2025-2033 Market Analysis: Trends, Dynamics, and Growth Opportunities

report thumbnailVentricular Assist Devices Market

Ventricular Assist Devices Market Future-proof Strategies: Trends, Competitor Dynamics, and Opportunities 2025-2033

report thumbnailCarcinoembryonic Antigen (CEA) Market

Carcinoembryonic Antigen (CEA) Market 2025 Trends and Forecasts 2033: Analyzing Growth Opportunities

report thumbnailForensic Technology Market

Forensic Technology Market Strategic Roadmap: Analysis and Forecasts 2025-2033

report thumbnailSteerable Needles Market

Steerable Needles Market 2025-2033 Overview: Trends, Competitor Dynamics, and Opportunities

report thumbnailExercise & Weight Loss Apps Market

Exercise & Weight Loss Apps Market 2025-2033 Overview: Trends, Competitor Dynamics, and Opportunities

report thumbnail3D Medical Imaging Devices Market

3D Medical Imaging Devices Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033

report thumbnailIntracranial Aneurysm Market

Intracranial Aneurysm Market Unlocking Growth Potential: Analysis and Forecasts 2025-2033

report thumbnailCartilage Repair Market

Cartilage Repair Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033

report thumbnailAnesthesia CO2 Absorbents Market

Anesthesia CO2 Absorbents Market Is Set To Reach 74.1 Million By 2033, Growing At A CAGR Of 5.2

report thumbnailMedical Tapes and Bandages Market

Medical Tapes and Bandages Market Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities

report thumbnailPreventive Healthcare Technologies and Services Market

Preventive Healthcare Technologies and Services Market Navigating Dynamics Comprehensive Analysis and Forecasts 2025-2033

report thumbnailCardiac Biomarkers Market

Cardiac Biomarkers Market 2025 to Grow at 12.8 CAGR with 9.4 Billion Market Size: Analysis and Forecasts 2033

report thumbnailBrachytherapy Devices Market

Brachytherapy Devices Market 2025-2033 Overview: Trends, Competitor Dynamics, and Opportunities

report thumbnailMedical Billing Outsourcing Market

Medical Billing Outsourcing Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033

report thumbnailAlopecia Market

Alopecia Market Future-Proof Strategies: Market Trends 2025-2033